Pending 2025 FDA Legislation on Pharmaceutical Development & Marketing: A Comprehensive Industry Impact Analysis
By: Shashank Upadhye Introduction The U.S. pharmaceutical landscape stands at a transformative juncture with several key legislative initiatives currently under Senate consideration. These proposed bills seek to enhance the drug development process, streamline regulatory pathways, with wide-ranging implications for market competition, drug pricing, and patient access to affordable medication. This article document analyzes the expected […]
